Drug
Allopregnanolone
Allopregnanolone is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 75.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
67%(2 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_2
3
50%
Ph phase_1
3
50%
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Not yet recruiting1
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (50.0%)
Phase 23 (50.0%)
Trials by Status
not_yet_recruiting117%
recruiting117%
completed350%
terminated117%
Recent Activity
1 active trials
Showing 5 of 6
not_yet_recruitingphase_2
Allopregnanolone in Chronic Complex Traumatic Brain Injury
NCT04003285
completedphase_1
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease
NCT06263010
terminatedphase_1
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
NCT03748303
recruitingphase_2
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
NCT04838301
completedphase_1
Effect of Allopregnanolone on Stress-induced Craving
NCT04015869
Clinical Trials (6)
Showing 6 of 6 trials
NCT04003285Phase 2
Allopregnanolone in Chronic Complex Traumatic Brain Injury
NCT06263010Phase 1
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease
NCT03748303Phase 1
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
NCT04838301Phase 2
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
NCT04015869Phase 1
Effect of Allopregnanolone on Stress-induced Craving
NCT02603926Phase 2
Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6